Cargando…

Ischemic stroke in PAR1 KO mice: Decreased brain plasmin and thrombin activity along with decreased infarct volume

BACKGROUND: Ischemic stroke is a common and debilitating disease with limited treatment options. Protease activated receptor 1 (PAR1) is a fundamental cell signaling mediator in the central nervous system (CNS). It can be activated by many proteases including thrombin and plasmin, with various down-...

Descripción completa

Detalles Bibliográficos
Autores principales: Shavit-Stein, Efrat, Mindel, Ekaterina, Gofrit, Shany Guly, Chapman, Joab, Maggio, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959388/
https://www.ncbi.nlm.nih.gov/pubmed/33720950
http://dx.doi.org/10.1371/journal.pone.0248431
_version_ 1783664960256081920
author Shavit-Stein, Efrat
Mindel, Ekaterina
Gofrit, Shany Guly
Chapman, Joab
Maggio, Nicola
author_facet Shavit-Stein, Efrat
Mindel, Ekaterina
Gofrit, Shany Guly
Chapman, Joab
Maggio, Nicola
author_sort Shavit-Stein, Efrat
collection PubMed
description BACKGROUND: Ischemic stroke is a common and debilitating disease with limited treatment options. Protease activated receptor 1 (PAR1) is a fundamental cell signaling mediator in the central nervous system (CNS). It can be activated by many proteases including thrombin and plasmin, with various down-stream effects, following brain ischemia. METHODS: A permanent middle cerebral artery occlusion (PMCAo) model was used in PAR1 KO and WT C57BL/6J male mice. Mice were evaluated for neurological deficits (neurological severity score, NSS), infarct volume (Tetrazolium Chloride, TTC), and for plasmin and thrombin activity in brain slices. RESULTS: Significantly low levels of plasmin and thrombin activities were found in PAR1 KO compared to WT (1.6±0.4 vs. 3.2±0.6 ng/μl, p<0.05 and 17.2±1.0 vs. 21.2±1.0 mu/ml, p<0.01, respectively) along with a decreased infarct volume (178.9±14.3, 134.4±13.3 mm(3), p<0.05). CONCLUSIONS: PAR1 KO mice have smaller infarcts, with lower thrombin and plasmin activity levels. These findings may suggest that modulation of PAR1 is a potential target for future pharmacological treatment of ischemic stroke.
format Online
Article
Text
id pubmed-7959388
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-79593882021-03-25 Ischemic stroke in PAR1 KO mice: Decreased brain plasmin and thrombin activity along with decreased infarct volume Shavit-Stein, Efrat Mindel, Ekaterina Gofrit, Shany Guly Chapman, Joab Maggio, Nicola PLoS One Research Article BACKGROUND: Ischemic stroke is a common and debilitating disease with limited treatment options. Protease activated receptor 1 (PAR1) is a fundamental cell signaling mediator in the central nervous system (CNS). It can be activated by many proteases including thrombin and plasmin, with various down-stream effects, following brain ischemia. METHODS: A permanent middle cerebral artery occlusion (PMCAo) model was used in PAR1 KO and WT C57BL/6J male mice. Mice were evaluated for neurological deficits (neurological severity score, NSS), infarct volume (Tetrazolium Chloride, TTC), and for plasmin and thrombin activity in brain slices. RESULTS: Significantly low levels of plasmin and thrombin activities were found in PAR1 KO compared to WT (1.6±0.4 vs. 3.2±0.6 ng/μl, p<0.05 and 17.2±1.0 vs. 21.2±1.0 mu/ml, p<0.01, respectively) along with a decreased infarct volume (178.9±14.3, 134.4±13.3 mm(3), p<0.05). CONCLUSIONS: PAR1 KO mice have smaller infarcts, with lower thrombin and plasmin activity levels. These findings may suggest that modulation of PAR1 is a potential target for future pharmacological treatment of ischemic stroke. Public Library of Science 2021-03-15 /pmc/articles/PMC7959388/ /pubmed/33720950 http://dx.doi.org/10.1371/journal.pone.0248431 Text en © 2021 Shavit-Stein et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Shavit-Stein, Efrat
Mindel, Ekaterina
Gofrit, Shany Guly
Chapman, Joab
Maggio, Nicola
Ischemic stroke in PAR1 KO mice: Decreased brain plasmin and thrombin activity along with decreased infarct volume
title Ischemic stroke in PAR1 KO mice: Decreased brain plasmin and thrombin activity along with decreased infarct volume
title_full Ischemic stroke in PAR1 KO mice: Decreased brain plasmin and thrombin activity along with decreased infarct volume
title_fullStr Ischemic stroke in PAR1 KO mice: Decreased brain plasmin and thrombin activity along with decreased infarct volume
title_full_unstemmed Ischemic stroke in PAR1 KO mice: Decreased brain plasmin and thrombin activity along with decreased infarct volume
title_short Ischemic stroke in PAR1 KO mice: Decreased brain plasmin and thrombin activity along with decreased infarct volume
title_sort ischemic stroke in par1 ko mice: decreased brain plasmin and thrombin activity along with decreased infarct volume
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959388/
https://www.ncbi.nlm.nih.gov/pubmed/33720950
http://dx.doi.org/10.1371/journal.pone.0248431
work_keys_str_mv AT shavitsteinefrat ischemicstrokeinpar1komicedecreasedbrainplasminandthrombinactivityalongwithdecreasedinfarctvolume
AT mindelekaterina ischemicstrokeinpar1komicedecreasedbrainplasminandthrombinactivityalongwithdecreasedinfarctvolume
AT gofritshanyguly ischemicstrokeinpar1komicedecreasedbrainplasminandthrombinactivityalongwithdecreasedinfarctvolume
AT chapmanjoab ischemicstrokeinpar1komicedecreasedbrainplasminandthrombinactivityalongwithdecreasedinfarctvolume
AT maggionicola ischemicstrokeinpar1komicedecreasedbrainplasminandthrombinactivityalongwithdecreasedinfarctvolume